Actualités et vidéos - HYTN INNOVATIONS MMOED - Anglais - Page 2

VANCOUVER, British Columbia, Feb. 20, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN " HYTN or The Company "), a leader in the cannabis sector known for specialized psychoactive and psychotropic product development, is excited to announce the expansion of its 100 mg Nano Shot Citrus (“ Nano Shot ”) to the key markets of British Columbia and Alberta. Following its initial success in Ontario, Canada's largest market, this move represents a significant stride in the company's...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 09, 2024 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (the “ Company ” or “ HYTN ”) (CSE: HYTN) is pleased to announce a non-brokered private placement of up to 13,333,334 units of the Company (“ Units ”) at a price of $0.075 per Unit (the “ Offering ”), for aggregate gross proceeds of up to $1,000,000.05. Each Unit will be composed of one (1) common...

VANCOUVER, British Columbia, Oct. 26, 2023 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (the “ Company ” or “ HYTN ”) (CSE: HYTN) is pleased to announce that it has closed its previously announced non-brokered private placement of units of the Company (“ Units ”) by issuing a total of 5,050,000 Units at a price of $0.10 per Unit (the “ Offering ”) for aggregate gross proceeds of $505,000. Each Unit consists of one (1) common share in the capital of the Company (a “ Share ”) and...

VANCOUVER, British Columbia, March 02, 2023 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“ HYTN ” or the “ Company ”) (CSE: HYTN), a Vancouver-based company specializing in the production of psychoactive and psychotropic compounds, announced today that it has submitted an amendment to its Controlled Drugs and Substances Dealers License with Health Canada. The amendment, if approved, will allow the company to expand its work to include additional compounds such as MDMA, ketamine, LSD,...

VANCOUVER, British Columbia, Feb. 23, 2023 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“ HYTN ” or the “ Company ”) (CSE: HYTN) announced that it has successfully initiated cultivation of psilocybin mushrooms under its Dealer’s License granted by Health Canada in accordance with the Controlled Drugs and Substances Act. This announcement is a significant development supporting HYTN's mission to be a leading manufacturer of psychoactive and psychotropic compounds. The company also...

VANCOUVER, British Columbia, Feb. 16, 2023 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“ HYTN ” or the “ Company ”) (CSE: HYTN), a leading manufacturer of products containing psychoactive and psychotropic compounds, including cannabis-derived cannabinoids, is pleased to provide an update on its Active Pharmaceutical Ingredient (API) portfolio. The Company's Kelowna, B.C. facility holds all available licenses and amendments under both the Cannabis Act and the Controlled Drugs and...

VANCOUVER, British Columbia, Nov. 30, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“ HYTN ” or the “ Company ”) (CSE: HYTN) announces that its wholly owned subsidiary, HYTN Cannabis Inc., has achieved 100% purchase fulfillment of its holiday specific offerings, delivering festive flavours to cannabis consumers across Canada. The products, which include THC infused Spiced Apple Cider and Mandarin Orange Nano-Gummies and Sparkling Beverages, were formulated specifically for the holiday...

VANCOUVER, British Columbia, Oct. 24, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“ HYTN ” or the “ Company ”) (CSE: HYTN) is pleased to announce that its wholly owned subsidiary, HYTN Cannabis Inc., has entered into a sales, distribution and marketing agreement (the “ Agreement ”) with Rose LifeScience Inc. (Rose ScienceVie) (“ Rose ”), a leading supplier of cannabis products in Quebec. The Agreement provides a path for HYTN to sell its products, through Rose, to la...

VANCOUVER, British Columbia, Oct. 17, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“ HYTN ” or the “ Company ”) (CSE: HYTN), a leading cannabis company focused on creating consistent, natural and delicious cannabis products, is pleased to announce that its wholly owned subsidiary, HYTN Cannabis Inc., has been awarded a Controlled Drugs and Substances Dealer’s Licence (the “ License ”) by Health Canada allowing for the sale, possession, production, assembly and transportation of...

VANCOUVER, British Columbia, Sept. 29, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“ HYTN ” or the “ Company ”) (CSE: HYTN) is pleased to announce that its wholly owned subsidiary, HYTN Cannabis Inc., has entered into a manufacturing agreement (the “ Agreement ”) with Tricanna Industries Inc. (“ Tricanna ”), a leading supplier of pre-rolled cannabis products. The Agreement leverages HYTN’s sales license, industry leading operational and quality management systems and...

VANCOUVER, British Columbia, Aug. 29, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“ HYTN ” or the “ Company ”) (CSE: HYTN) is pleased to announce that, through its wholly owned subsidiary, HYTN Cannabis Inc., it has successfully developed and listed for sale its all-new Nano Gummies product (the “ Nano Gummies ”). The Nano Gummies, which feature the Company’s proprietary Elevation Technology, deliver a rapid and predictable cannabis experience and complement the Company’s...

VANCOUVER, British Columbia, Aug. 23, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“ HYTN ” or the “ Company ”) (CSE: HYTN) is pleased to announce that its wholly owned subsidiary, HYTN Cannabis Inc., has been awarded a license (the “ License ”) by Health Canada allowing for the sale of cannabis for medical purposes (with possession). This announcement follows a list of license achievements including a Standard Processing License, Cannabis Research License, an Amendment for Sale...

VANCOUVER, British Columbia, June 14, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“ HYTN ” or the “ Company ”) (CSE: HYTN) announces that its wholly owned subsidiary, HYTN Cannabis Inc., has received a license amendment (the “ License Amendment ”) from Health Canada allowing for the cultivation of cannabis. This License Amendment further strengthens HYTN's regulatory approvals which include a Standard Processing License, a Research License and an Amendment for Sale of Cannabis to...

VANCOUVER, British Columbia, May 31, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“ HYTN ” or the “ Company ”) (CSE: HYTN) is pleased to report certain highlights from its Q2 financial statements (the “ Q2 Results ”) for the three and six months ended March 31, 2022. The Q2 Results reflect the details of HYTN’s reverse-take-over (“ RTO ”) of Mount Dakota Energy Corp. and the Company’s financial position post-RTO. The Company notes that the complexity of the Q2 Results was...

VANCOUVER, British Columbia, March 30, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“ HYTN ” or the “ Company ”) (CSE: HYTN) is pleased to announce that it has successfully sold cannabis flower to serve the Australian medical cannabis market under the Promethean BioPharma brand (“ Promethean ”) pursuant to the Company’s supply agreement (the “ Agreement ”) with TCann Pty Ltd. (“ TCann ”). “HYTN has been sourcing superior dry flower cannabis inputs for its infused...

VANCOUVER, British Columbia, March 17, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (" HYTN " or the " Company ) (CSE: HYTN) is pleased to announce that it has begun accepting orders directly from Provincial buyers. This news builds on HYTN’s February 22 announcement that it had been awarded approval to sell cannabis products to provincially and territorially authorized retailers and that the Company was preparing to transition away from its partnership with Emerald Health Therapeutics, Inc....

VANCOUVER, British Columbia, March 02, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“ HYTN ” or the “ Company ”) (CSE: HYTN) is pleased to report unaudited Q1 financial results (the “ Q1 Results ”) for its operating subsidiary, HYTN Beverage Corp. (“ HYTN Beverage ”), for the quarter ended December 31, 2021 (“ Q1 ”). The Q1 Results demonstrate HYTN’s path to commercialization as HYTN Beverage generated total sales of $212,581 during the Q1. This swift path to revenue was...

VANCOUVER, British Columbia, Feb. 28, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“ HYTN ” or the “ Company ”) (CSE: HYTN) is pleased to announce that, through a manufacturing and sales agreement (the “ Agreement ”) with Promethean BioPharma (“ Promethean ”), it has successfully developed, exported and launched cannabis nano-emulsions featuring HYTN’s proprietary Elevation Technology® into the Australian medical cannabis market. The products being formulated and...

VANCOUVER, British Columbia, Feb. 24, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (“ HYTN ” or the “ Company ”) (CSE: HYTN) is pleased to introduce the industry leaders serving on its board of directors (the “ Board ”). The Board is composed of HYTN founders, Elliot McKerr and Jason Broome, and is strengthened with the additions of Vic Neufeld, Dennis Staudt and Eli Dusenbery. Mr. Neufeld has had a long career in the natural health and cannabis industries, highlighted by his time...

Toronto, Ontario--(Newsfile Corp. - le 18 février/February 2022) - (This Bulletin has been amended to remove details of a previous consolidation from February 2021.) The current CUSIP/ISIN are correct reflecting only the name change from Mount Dakota Energy Corp. to HYTN Innovations Inc. The common shares of HYTN Innovations Inc., previously listed as Mount Dakota Energy Corp., have been approved for listing on the CSE. Listing and disclosure documents will be available at www.thecse.com on the...